239 related articles for article (PubMed ID: 21750563)
1. The KCa3.1 blocker TRAM-34 reduces infarction and neurological deficit in a rat model of ischemia/reperfusion stroke.
Chen YJ; Raman G; Bodendiek S; O'Donnell ME; Wulff H
J Cereb Blood Flow Metab; 2011 Dec; 31(12):2363-74. PubMed ID: 21750563
[TBL] [Abstract][Full Text] [Related]
2. The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke.
Chen YJ; Nguyen HM; Maezawa I; Grössinger EM; Garing AL; Köhler R; Jin LW; Wulff H
J Cereb Blood Flow Metab; 2016 Dec; 36(12):2146-2161. PubMed ID: 26661208
[TBL] [Abstract][Full Text] [Related]
3. Targeting of microglial KCa3.1 channels by TRAM-34 exacerbates hippocampal neurodegeneration and does not affect ictogenesis and epileptogenesis in chronic temporal lobe epilepsy models.
Ongerth T; Russmann V; Fischborn S; Boes K; Siegl C; Potschka H
Eur J Pharmacol; 2014 Oct; 740():72-80. PubMed ID: 25016931
[TBL] [Abstract][Full Text] [Related]
4. Repurposing the K
Lee RD; Chen YJ; Nguyen HM; Singh L; Dietrich CJ; Pyles BR; Cui Y; Weinstein JR; Wulff H
Transl Stroke Res; 2024 Jun; 15(3):518-532. PubMed ID: 37088858
[TBL] [Abstract][Full Text] [Related]
5. KCa3.1 inhibition switches the phenotype of glioma-infiltrating microglia/macrophages.
Grimaldi A; D'Alessandro G; Golia MT; Grössinger EM; Di Angelantonio S; Ragozzino D; Santoro A; Esposito V; Wulff H; Catalano M; Limatola C
Cell Death Dis; 2016 Apr; 7(4):e2174. PubMed ID: 27054329
[TBL] [Abstract][Full Text] [Related]
6. Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death.
Xu J; Culman J; Blume A; Brecht S; Gohlke P
Stroke; 2003 May; 34(5):1287-92. PubMed ID: 12677021
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of urinary trypsin inhibitor against focal cerebral ischemia-reperfusion injury in rats.
Yano T; Anraku S; Nakayama R; Ushijima K
Anesthesiology; 2003 Feb; 98(2):465-73. PubMed ID: 12552207
[TBL] [Abstract][Full Text] [Related]
8. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.
Culman J; Nguyen-Ngoc M; Glatz T; Gohlke P; Herdegen T; Zhao Y
Exp Neurol; 2012 Dec; 238(2):243-53. PubMed ID: 22995601
[TBL] [Abstract][Full Text] [Related]
9. Ocimum sanctum attenuates oxidative damage and neurological deficits following focal cerebral ischemia/reperfusion injury in rats.
Ahmad A; Khan MM; Raza SS; Javed H; Ashafaq M; Islam F; Safhi MM; Islam F
Neurol Sci; 2012 Dec; 33(6):1239-47. PubMed ID: 22278208
[TBL] [Abstract][Full Text] [Related]
10. Blood-brain barrier KCa3.1 channels: evidence for a role in brain Na uptake and edema in ischemic stroke.
Chen YJ; Wallace BK; Yuen N; Jenkins DP; Wulff H; O'Donnell ME
Stroke; 2015 Jan; 46(1):237-44. PubMed ID: 25477223
[TBL] [Abstract][Full Text] [Related]
11. Effects and Mechanism of Action of Inducible Nitric Oxide Synthase on Apoptosis in a Rat Model of Cerebral Ischemia-Reperfusion Injury.
Zheng L; Ding J; Wang J; Zhou C; Zhang W
Anat Rec (Hoboken); 2016 Feb; 299(2):246-55. PubMed ID: 26598930
[TBL] [Abstract][Full Text] [Related]
12. Pre-treatment with the synthetic antioxidant T-butyl bisphenol protects cerebral tissues from experimental ischemia reperfusion injury.
Duong TT; Chami B; McMahon AC; Fong GM; Dennis JM; Freedman SB; Witting PK
J Neurochem; 2014 Sep; 130(6):733-47. PubMed ID: 24766199
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of lercanidipine in middle cerebral artery occlusion model of stroke in rats.
Gupta S; Sharma U; Jagannathan NR; Gupta YK
Exp Neurol; 2017 Feb; 288():25-37. PubMed ID: 27794423
[TBL] [Abstract][Full Text] [Related]
14. The Ca2+-activated K+ channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration.
Kaushal V; Koeberle PD; Wang Y; Schlichter LC
J Neurosci; 2007 Jan; 27(1):234-44. PubMed ID: 17202491
[TBL] [Abstract][Full Text] [Related]
15. Blood micromolar concentrations of kaempferol afford protection against ischemia/reperfusion-induced damage in rat brain.
López-Sánchez C; Martín-Romero FJ; Sun F; Luis L; Samhan-Arias AK; García-Martínez V; Gutiérrez-Merino C
Brain Res; 2007 Nov; 1182():123-37. PubMed ID: 17950707
[TBL] [Abstract][Full Text] [Related]
16. Kv1.3 channel blockade alleviates cerebral ischemia/reperfusion injury by reshaping M1/M2 phenotypes and compromising the activation of NLRP3 inflammasome in microglia.
Ma DC; Zhang NN; Zhang YN; Chen HS
Exp Neurol; 2020 Oct; 332():113399. PubMed ID: 32652099
[TBL] [Abstract][Full Text] [Related]
17. Isoquercetin attenuates oxidative stress and neuronal apoptosis after ischemia/reperfusion injury via Nrf2-mediated inhibition of the NOX4/ROS/NF-κB pathway.
Dai Y; Zhang H; Zhang J; Yan M
Chem Biol Interact; 2018 Mar; 284():32-40. PubMed ID: 29454613
[TBL] [Abstract][Full Text] [Related]
18. Gastrodin pretreatment alleviates rat brain injury caused by cerebral ischemic-reperfusion.
Li S; Bian L; Fu X; Ai Q; Sui Y; Zhang A; Gao H; Zhong L; Lu D
Brain Res; 2019 Jun; 1712():207-216. PubMed ID: 30742808
[TBL] [Abstract][Full Text] [Related]
19. The phosphodiesterase-4 inhibitor, FCPR16, attenuates ischemia-reperfusion injury in rats subjected to middle cerebral artery occlusion and reperfusion.
Chen J; Yu H; Zhong J; Feng H; Wang H; Cheng Y; Zou Z; Huang C; Zhou Z; Zheng W; Xu J
Brain Res Bull; 2018 Mar; 137():98-106. PubMed ID: 29155261
[TBL] [Abstract][Full Text] [Related]
20. The neuroprotective effect of agmatine after focal cerebral ischemia in diabetic rats.
Cui H; Lee JH; Kim JY; Koo BN; Lee JE
J Neurosurg Anesthesiol; 2012 Jan; 24(1):39-50. PubMed ID: 21993016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
